Paper39350146
Heparin therapy in sepsis and sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis.
Totoki T and 6 others. Thromb J, 2024. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Heparin therapy in sepsis and sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis. Papers, record 39350146. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39350146
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Heparin therapy in sepsis and sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37359014 | Low-molecular-weight heparin therapy reduces 28-day mortality in patients with sepsis-3 by improving inflammation and coagulopathy. | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/37359014 | PubMed |
| 2 | 33824483 | Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. | Nat Rev Immunol | 2021 | https://conductscience.org/library/papers/33824483 | PubMed |
| 3 | 25493972 | The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis. | Crit Care Med | 2015 | https://conductscience.org/library/papers/25493972 | PubMed |
| 4 | 32558075 | Coagulopathy in COVID-19. | J Thromb Haemost | 2020 | https://conductscience.org/library/papers/32558075 | PubMed |
| 5 | 30449812 | Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation. | Intern Med | 2019 | https://conductscience.org/library/papers/30449812 | PubMed |
| 6 | 31462531 | RoB 2: a revised tool for assessing risk of bias in randomised trials. | BMJ | 2019 | https://conductscience.org/library/papers/31462531 | PubMed |
| 7 | 34617959 | Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial. | JAMA Intern Med | 2021 | https://conductscience.org/library/papers/34617959 | PubMed |
| 8 | 31954465 | Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. | Lancet | 2020 | https://conductscience.org/library/papers/31954465 | PubMed |
| 9 | 33186991 | Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality. | Thromb Haemost | 2020 | https://conductscience.org/library/papers/33186991 | PubMed |
| 10 | 35836009 | Race does matter: venous thromboembolism in trauma patients with isolated severe pelvic fractures. | Eur J Trauma Emerg Surg | 2023 | https://conductscience.org/library/papers/35836009 | PubMed |
| 11 | 15221932 | Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2). | J Pathol | 2004 | https://conductscience.org/library/papers/15221932 | PubMed |
| 12 | 37256226 | Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37256226 | PubMed |
| 13 | 26903338 | The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). | JAMA | 2016 | https://conductscience.org/library/papers/26903338 | PubMed |
| 14 | 33782057 | The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. | BMJ | 2021 | https://conductscience.org/library/papers/33782057 | PubMed |
| 15 | 27181297 | Efficacy and safety of low-molecular-weight heparin in patients with sepsis: a meta-analysis of randomized controlled trials. | Sci Rep | 2016 | https://conductscience.org/library/papers/27181297 | PubMed |
| 16 | 27479532 | Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation. | Thromb Res | 2016 | https://conductscience.org/library/papers/27479532 | PubMed |
| 17 | 33095849 | Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial. | JAMA | 2020 | https://conductscience.org/library/papers/33095849 | PubMed |
| 18 | 35062871 | Unfractionated heparin improves the clinical efficacy in adult sepsis patients: a systematic review and meta-analysis. | BMC Anesthesiol | 2022 | https://conductscience.org/library/papers/35062871 | PubMed |
| 19 | 25023776 | Unfractionated heparin suppresses lipopolysaccharide-induced monocyte chemoattractant protein-1 expression in human microvascular endothelial cells by blocking Krüppel-like factor 5 and nuclear factor-κB pathway. | Immunobiology | 2014 | https://conductscience.org/library/papers/25023776 | PubMed |
| 20 | 12664219 | 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. | Intensive Care Med | 2003 | https://conductscience.org/library/papers/12664219 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42973830 | Opening the Door for the New Era of Managing Sepsis-induced Coagulopathy. | Juntendo Med J | 2026 | https://conductscience.org/library/papers/42973830 | PubMed |
| 42903397 | Anticoagulants beyond coagulation: repurposing heparin to mitigate immunothrombosis and inflammatory cascades in sepsis. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42903397 | PubMed |
| 42851353 | Longitudinal sepsis-induced coagulopathy score trajectories and mortality in relation to early prophylactic heparin: a multicentre cohort study. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42851353 | PubMed |
| 42835425 | Early systemic heparin exposure is associated with lower mortality, reduced disseminated intravascular coagulation, and fewer thrombotic complications in septic shock. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42835425 | PubMed |
| 42286503 | The U-shaped relationship between triglyceride glucose-body mass index and prognosis of sepsis patients: a retrospective study. | BMC Infect Dis | 2026 | https://conductscience.org/library/papers/42286503 | PubMed |
| 41901308 | Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related Therapeutics. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41901308 | PubMed |
| 41598427 | Recognizing Coagulation Disorders in Sepsis in the Emergency Room: A Narrative Review. | J Clin Med | 2026 | https://conductscience.org/library/papers/41598427 | PubMed |
| 41331689 | Efficacy and safety of anticoagulant therapy in patients with sepsis: a meta-analysis of randomized controlled trials. | Thromb J | 2025 | https://conductscience.org/library/papers/41331689 | PubMed |
| 41306966 | Influence of heparin-based anticoagulants on antibiotic therapy. | Front Immunol | 2025 | https://conductscience.org/library/papers/41306966 | PubMed |
| 41193583 | The impact of continuous intravenous administration of heparin on coagulation dysfunction and organ failure in patients with sepsis. | Sci Rep | 2025 | https://conductscience.org/library/papers/41193583 | PubMed |
| 40740948 | Reevaluating anticoagulation therapy for sepsis-associated disseminated intravascular coagulation based on endothelial glycocalyx shedding quantification: a single-center, retrospective, observational pilot study. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40740948 | PubMed |
| 40083381 | Unfractionated heparin may improve near-term survival in patients admitted to the ICU with sepsis attributed to pneumonia: an observational study using the MIMIC-IV database. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40083381 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39350146
GET https://conductscience.org/api/papers/v1/39350146/references?page=2